My friend translated as well. This is the relevant section (the second half basically). I am only posting this as an FYI. It is my opinion that this article is not based on any facts.
"The article is from "Science" magazine. It talks about how Obama lifted the ban on embryonic stem cell research. There are two companies discussed in the article, Genron Corporation and Adv. Cell Tech. Below is the translation:
On January 23, 2009, FDA approved Genron Corp's injecting GRNOPC1 for patients with spinal injuries leading to paraplegia. If they were successful, they would have conducted Phase III clinical trial over the summer. However, there is a slight setback as Phase III trials were not carried out. Current reason is unknown as FDA is still gathering data on the animal experiments.
On November 18, Adv. Cell Tech submitted their application for Phase II clinical trials to the FDA. It's the world's second case of human embryonic stem cells and clinical trials recently approved by the U.S. FDA has formally launched a clinical trial.
ACT's embryonic stem cell clinical trial project is aimed at hereditary eye disease.
New Jersey project participants of the Macro Zarbin University School of Medicine, said that he is cautious but optimistic about the project. Compared with other experiments, the stem cells in the retina is more likely to play a significant role.
According to the ACT introduction, Robert Lanza conducted previous animal experiments. He showed that using embryonic stem cells to treat Stargardt disease (a hereditary eye disease) are very effective and there were no toxic side effects. This allows us to believe that human trials will be successful.
In Poland, Casey Eye Institute will also participate in the clinical trials, says Peter Francis. The FDA is confident of the preliminary data from animal experiments that they accepted their application for approval. If approved next year, their clinical trials will carry out for six months.
Bio-Link Comment: stem cells and regenerative medicine, these words will become the most popular topic in the next few years. Many people are excited as it's finally out of the theoretical research laboratories in into the clinical path. The significance of clinical trials brings stem cell therapy closer to reality. No matter what difficulties lies ahead, I believe the scientists will continue to move forward. (***This is a comment made by the author)"
News 
Market Data 
Discover 
AI
